Pregnancy outcome after uterine artery embolization for uterine adenomyosis: A systematic review
review
OA: closed
public-domain-us
Abstract
BACKGROUND: Uterine adenomyosis involves the growth of endometrial gland and stroma within the uterine musculature. Patients with uterine adenomyosis experience heavy painful periods, deep dyspareunia and subfertility, reducing their overall quality of life. Hysterectomy is usually the recommended treatment for such patients. Whilst uterine artery embolization (UAE) offers a suitable, fertility-preserving alternative, for patients who have not completed their families, its impacts on pregnancy outcomes have not yet been explored or studied in women with pure adenomyosis.
OBJECTIVE: The objective of the current study was to assess pregnancy and live birth rates in women with pure adenomyosis, treated with UAE.
SEARCH STRATEGY: A comprehensive systematic review of the published literature, in Pubmed, Embase, Cochrane, Google Scholar, Scopus and ClinicalTrials.gov, was performed from January 2000 until January 2025.
SELECTION CRITERIA: All the published and unpublished literature in English language, describing pregnancy outcome after uterine artery embolization for pure uterine adenomyosis, were eligible for inclusion in the study.
DATA COLLECTION AND ANALYSIS: Data about preconception characteristics, pregnancy, obstetrics and neonatal outcomes were extracted and analyzed according to the study design source and pregnancy viability.
MAIN RESULTS: We identified nine papers, with a total cohort of 578 patients, of which 208 desiring fertility. Women were aged 18-52, with a mean follow up of 46.3 months after UAE. We concluded a pregnancy rate of 41.20% (n = 28) and a live birth rate of 95.70% (n = 23) in this cohort. Of these, seven studies reported obstetric and/or neonatal complications, including preterm, premature rupture of membranes, hemorrhage during delivery, low birth weight and neonatal deaths.
CONCLUSION: The current study showed that the pregnancy rates after uterine artery embolization are comparable to assisted conception clinical success rates for women with uterine adenomyosis, but with markedly higher live birth rates. UAE provides a foundation for further studies and research, directly assessing pregnancy outcomes and indirectly assessing the fertility potential in women with pure adenomyosis, with the potential to influence uterine adenomyosis treatment guidelines. Our research provides a foundation on which healthcare professionals can effectively counsel and treat fertility preserving women with pure uterine adenomyosis.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- Clinical investigation of fertility after uterine artery embolization via openalex
- Diagnostic delay for superficial and deep endometriosis in the United Kingdom via openalex
- Factors associated with dysmenorrhoea and menorrhagia improvement in patients with adenomyosis after uterine artery embolisation via openalex
- Long‐term durability of uterine artery embolisation for treatment of symptomatic adenomyosis via openalex
- Long-Term Results of Uterine Artery Embolization for Symptomatic Adenomyosis via openalex
- New paradigms in the conservative surgical and interventional management of adenomyosis via openalex
- Spontaneous Pregnancy with a Live Birth after Conventional and Partial Uterine Fibroid Embolization via openalex
- Uterine adenomyosis: a need for uniform terminology and consensus classification via openalex
- Uterine Artery Embolization for the Treatment of Adenomyosis: A Systematic Review and Meta-Analysis via openalex
- Uterine artery embolization using gelatin sponge particles for symptomatic focal and diffuse adenomyosis via openalex
- W4293043486 via openalex
- W4321460722 via openalex
- W4385202020 via openalex
- W4408230220 via openalex
- W1963621667 via openalex
- W4415096822 via openalex
- W2034183046 via openalex
- W2042677510 via openalex
- W2083467689 via openalex
- W2114488753 via openalex
- W2134068782 via openalex
- W2922267617 via openalex
- W2966047758 via openalex
- W3032384857 via openalex
- W4206050319 via openalex
Source provenance
- europepmc
- last seen: 2026-09-12T06:55:35.949492+00:00
- openalex
- last seen: 2026-09-12T06:45:54.676558+00:00
- pubmed
- last seen: 2026-09-12T06:47:42.855705+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine